We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$7.15B
AUM Growth
+$778M
Cap. Flow
+$799M
Cap. Flow %
11.18%
Top 10 Hldgs %
9.56%
Holding
5,720
New
998
Increased
1,852
Reduced
1,702
Closed
889

Sector Composition

Rank Sector Weight
1 Healthcare 3.37%
2 Technology 1.88%
3 Consumer Discretionary 1.68%
4 Energy 1.47%
5 Financials 1.28%

Similar funds

Group One Trading's Q2 2015 Portfolio in Review

As of Q2 2015, Group One Trading held 5,720 positions worth $7.15B, up 12% from $6.37B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Group One Trading deployed $799M of net new capital in Q2 2015, opening 998 new positions and adding to 1,852 existing holdings. Its largest new stake was Viatris: 122,934 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, up from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Allergan plc, an estimated $21.2M trimmed.

  • Group One Trading's largest Q2 2015 buy was Viatris: 122,934 shares worth $8.34M.
  • Group One Trading added most to Williams Companies in Q2 2015, an estimated $22.3M increase.
  • Group One Trading's biggest Q2 2015 reduction was Allergan plc, cutting an estimated $21.2M.
  • Group One Trading fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $89.2M.
  • Group One Trading's ten largest holdings make up 9.6% of its $7.15B portfolio in Q2 2015.
  • Group One Trading opened 998 new positions and closed 889 in Q2 2015.
  • Group One Trading's portfolio value rose 12% quarter-over-quarter to $7.15B.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.